RecruitingNCT03748069

Influenza Associated Aspergillosis In-depth Investigation

Unraveling the Pathogenesis of Influenza-associated Aspergillosis: a Single-center, Prospective Cohort Pilot Study

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

45 participants

Start Date

Jan 18, 2019

Study Type

OBSERVATIONAL

Conditions

Invasive Pulmonary Aspergillosis Influenza With Pneumonia

Summary

This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with influenza with pneumonia and invasive pulmonary aspergillosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.